Nadex Advertisement
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

NanoViricides Inc. (NNVC)

Add NNVC Price Alert      Hide Sticky   Hide Intro
Moderator: Steady_T, NewMoney, drkazmd65
Search This Board: 
Last Post: 7/26/2017 8:31:42 PM - Followers: 464 - Board type: Free - Posts Today: 0

NanoViricides, Inc (NNVC)

Company Address:
135 Wood St, Suite 200
West Haven, CT 06516
Phone:  203-937-6137
Fax:  203-859-5095
CIK:  0001379006
NanoViricides, Inc. is a development stage company with a unique nanomedicine technology. The Company is developing nanotechnology-based biomimetic anti-viral medicines, that we call "nanoviricides®". 
A "nanoviricide" is an antiviral agent designed by the Company to fool a virus into attaching to this agent in the same way that the virus normally attaches to receptors on a cell surface. Once attached, the flexible nanoviricide glob would wrap around the virus and trap it. In the process, the virus could lose its coat proteins that it needs to bind to a cell. The virus is thus neutralized and effectively destroyed. Nanoviricides are designed to complete the task of dismantling the virus particle without immune system assistance.
Thus nanoviricides represent the next great advance in "Immunotherapeutics" (antibodies and vaccines,) the well established antiviral strategies. Viruses have developed smart strategies to derail immune system function. This results in failure of antibodies and vaccines.
The nanoviricide technology attempts to circumvent virus escape that results from natural changes in virus structure. Despite all such changes, the cell receptor to which a virus binds remains the same. Nanoviricides mimic this conserved feature of virus binding to its host cell receptor. If a virus "escapes" a properly designed nanoviricide, it would have a reduced ability to attach to the cell receptor and would have become much less pathogenic in the process.
Recent News:

Micrographic images of nanoviricide micelles in action against Murine Cytomegalovirus:

SEC Filings:
Share Structure:  See SEC filings for current share structure
Investor Relations:
Amanda Schuon, 310-550-7200


All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement:
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
NNVC News: NanoViricides Reports Its Drug Candidates Significantly Reduced the Extent of Shingles Virus Infection of Human Skin 07/10/2017 07:00:00 AM
NNVC News: NanoViricides' Poster "Novel NanoviricidesĀ® Highly Effective Against Varicella Zoster Virus in Cell Culture" to be Presented... 06/26/2017 09:00:00 AM
NNVC News: NanoViricides Abstract Accepted for Poster Presentation at the 2017 Annual Meeting of American Society of Virology 06/20/2017 07:00:00 AM
NNVC News: NanoViricides CEO to Present Information on Its Topical Shingles Treatment At the 2017 Marcum Investor Conference in New York... 06/13/2017 07:00:00 AM
NNVC News: NanoViricides Reports Excellent Inhibitory Effects of Its Topical Shingles Treatment Candidates Against VZV in Multiple Cell ... 06/06/2017 05:30:00 PM
#134077  Sticky Note Someone suggested it is 'not possible' to have CM_INV 07/11/17 10:42:24 PM
#126117  Sticky Note A solid step forward: NanoViricides Signs Agreement drkazmd65 10/31/16 07:46:04 AM
#134458   But, hey, it's a scam according to this arvitar 07/26/17 08:31:42 PM
#134455   It doesn't matter now whether or not NNVC arvitar 07/26/17 02:59:21 PM
#134451   C'mon, you know you'll be back. Its_lose_not_loose 07/26/17 02:09:38 PM
#134449   That's a question only you can answer. Its_lose_not_loose 07/26/17 02:04:06 PM
#134447   Not everybody. There are plenty here who Its_lose_not_loose 07/26/17 02:00:45 PM
#134445   There is zero proof of any. Ubertino 07/26/17 01:55:52 PM
#134444   What's the big deal with the next report arvitar 07/26/17 12:21:10 PM
#134443   What's the big deal with the next report NewMoney 07/26/17 11:45:51 AM
#134442   There's hope for you yet. Its_lose_not_loose 07/26/17 10:03:24 AM
#134441   WHAT MEDICAL DISCOVERY? Trendliner 07/26/17 10:01:14 AM
#134440   Thanks for a dose of realism in an Its_lose_not_loose 07/26/17 09:58:33 AM
#134438   For the greatest medical discovery in history that Ubertino 07/26/17 09:39:50 AM
#134437   NNVC's financial crises would not be solved by arvitar 07/26/17 09:35:09 AM
#134436   Thanks for the ray of sunshine in this Its_lose_not_loose 07/26/17 09:26:41 AM
#134435   No clue. Ubertino 07/26/17 09:24:48 AM
#134434   When will we see the published results? Any idea? Its_lose_not_loose 07/26/17 09:18:52 AM
#134432   Saying you have "the greatest discovery in medical Steady_T 07/25/17 11:52:09 PM
#134431   OH.... The stories we can tell the grandchildren. arvitar 07/25/17 10:54:00 PM
#134430   Short Interest 7/14/17 1,916,722 Straynut 07/25/17 10:29:14 PM
#134427   I have never said the company is a Steady_T 07/25/17 07:45:07 PM
#134426   Why would any of that matter? arvitar 07/25/17 07:31:46 PM
#134424   You almost sound like you believe it's a Ubertino 07/25/17 05:34:39 PM
#134423   So Moffat has figured out how to make Steady_T 07/25/17 04:06:48 PM
#134422   "..NNVC never registered, nor could have registered, the loanranger 07/25/17 03:43:20 PM
#134420   Another possible explanation is that Seymour has lost arvitar 07/25/17 02:32:59 PM
#134419   Ah, so if you say you have a Its_lose_not_loose 07/25/17 02:28:13 PM
#134418   Builds usage - can speed issue of the Ubertino 07/25/17 02:18:53 PM
#134417   I wonder if the poster explains the trademarked Its_lose_not_loose 07/25/17 02:18:28 PM
#134416   Why is NNVC using trademarks for products they Its_lose_not_loose 07/25/17 02:12:44 PM
#134415   And don't forget the impact that GSK will provide! Ubertino 07/25/17 02:10:27 PM
#134414   I leave "folding up tent" to Abu Ben Adhem. Ubertino 07/25/17 02:09:12 PM
#134413   Moffat's results were already PR'd: arvitar 07/25/17 12:20:48 PM
#134412   My bad. I've heard such spectacular things about Its_lose_not_loose 07/25/17 12:11:11 PM
#134411   Sure, a very high share price for a arvitar 07/25/17 11:59:24 AM
#134410   But... what if the share price rose to, Its_lose_not_loose 07/25/17 11:50:59 AM
#134409   NNVC could resolve all their issues today, and arvitar 07/25/17 11:43:43 AM
#134408   I think we need to examine more closely Its_lose_not_loose 07/25/17 11:31:25 AM
#134406   I'd think any willful misrepresentation to the investing arvitar 07/25/17 10:15:10 AM
#134405   Isn't the bigger issue, then, that NNVC uses Its_lose_not_loose 07/25/17 10:05:03 AM
#134404   If I understood correctly, LR explained that NNVC arvitar 07/25/17 10:01:33 AM
#134403   How will yet another PR about Moffat's results arvitar 07/25/17 09:58:01 AM
#134402   I've decided I'm going to apply for the Its_lose_not_loose 07/25/17 09:56:09 AM
#134401   Too bad NNVC doesn't hold the trademarks on Its_lose_not_loose 07/25/17 09:47:59 AM
#134400   What happened to the HerpeCide trademark? Why did Its_lose_not_loose 07/25/17 09:41:31 AM
#134399   Believe what you like...but we all know that Magnus1 07/25/17 09:36:35 AM
#134398   And yet, these so-called "cides" have yet to Its_lose_not_loose 07/25/17 09:28:10 AM
#134397   Common knowledge! Ubertino 07/25/17 07:33:53 AM
#134396   I need only one word in reply. Ubertino 07/25/17 07:30:58 AM
#134395   GSK needs Cides to succeed! Ubertino 07/25/17 07:29:20 AM